Wedbush Raises Imax to $62 on Box Growth - Nov 6

The Story

Wedbush has raised its price target for IMAX to $62, attributing the move to box-office growth, according to Investing.com. The update highlights renewed analyst confidence in $IMAX after improving theatrical demand.

Why It Matters For Your Portfolio

• Price target change: Wedbush set a $62 target for $IMAX, a direct analyst signal that can influence market expectations and sector sentiment.
• Box-office momentum: The firm cited box-office growth as the catalyst, and key metrics referenced include 90.46% and 38.01%, which may point to stronger revenue trends for exhibitors and IMAX partners.
• Valuation and earnings cues: Additional data points to watch include 0.67%, $1.02, and $168.53, which investors can use when rechecking margin and per-share assumptions for $IMAX.
• Near-term catalyst: IMAX is estimated to report Q3 2026 earnings on Thursday, a scheduled event that could validate or challenge the new target and move the stock.

The Trade

Growth investors and traders should note the upgrade as a momentum signal but treat the upcoming Q3 report as the primary catalyst to confirm fundamentals. Watch the Q3 results and the metrics listed above for signs that box-office strength is translating into revenue and EPS improvements. Will the Q3 print validate the higher target? Monitor reaction and volatility around the earnings release.